ArticleIJU case reports2026

Pathological Complete Response to Nivolumab Plus Ipilimumab Combination Therapy in Advanced Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus.

Takuto Tsuchiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.